Skip to main content

What the FDA labels say about taking them together

Enalapril and tamsulosin

Tamsulosin's FDA label of December 1, 2025 names enalapril in its drug interactions section; the enalapril labels PlainMeds reads (2) do not name tamsulosin. The tamsulosin label: “Dosage adjustments are not necessary when tamsulosin hydrochloride capsules are administered concomitantly with nifedipine, atenolol, or enalapril.”

Check it at the source: the enalapril FDA label on DailyMed (effective January 23, 2026, Bausch Health US LLC); the tamsulosin FDA label on DailyMed (effective December 1, 2025, Synthon Pharmaceuticals, Inc.).

What does the enalapril label say about tamsulosin?

Enalapril's label (effective January 23, 2026) and its 1 other brand-application label do not name tamsulosin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Vasotec), Bausch Health US LLC, effective January 23, 2026 (SPL set 39631f1f-5d19-43c1-b504-bf56d991ed97), via openFDA; the full label on DailyMed

What does the tamsulosin label say about enalapril?

Tamsulosin label, drug interactions

Dosage adjustments are not necessary when tamsulosin hydrochloride capsules are administered concomitantly with nifedipine, atenolol, or enalapril [see Clinical Pharmacology (12.3) ].

Source: FDA drug label (Tamsulosin hydrochloride), Synthon Pharmaceuticals, Inc., effective December 1, 2025 (SPL set 13a5032d-0be1-4001-916e-459f0b1a051d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

28Enalapril generic labelers
38Tamsulosin generic labelers
EnalaprilTamsulosin
Labeled forHigh blood pressure, Heart failureEnlarged prostate (BPH)
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0664 per tablet 10 mg tablet$0.05 per capsule 0.4 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?